{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:17:43Z","timestamp":1774419463833,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008510","name":"University of Maryland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006636","name":"University of Maryland Baltimore County","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011319","name":"Skin Treatment and Research Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.dmd.2025.100178","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:34:02Z","timestamp":1760027642000},"page":"100178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Fludarabine metabolism by cytosolic 5\u2032-nucleotidase III and its tissue-specific localization mapping using mass spectrometry imaging"],"prefix":"10.1016","volume":"53","author":[{"given":"Maisa","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nav Raj","family":"Phulara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7221-7060","authenticated-orcid":false,"given":"Herana Kamal","family":"Seneviratne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.dmd.2025.100178_bib1","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.1007\/s00253-021-11547-w","article-title":"Microbial 5'-nucleotidases: their characteristics, roles in cellular metabolism, and possible practical applications","volume":"105","author":"Zakataeva","year":"2021","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"10.1016\/j.dmd.2025.100178_bib2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","article-title":"Cellular function and molecular structure of ecto-nucleotidases","volume":"8","author":"Zimmermann","year":"2012","journal-title":"Purinergic Signal"},{"issue":"4","key":"10.1016\/j.dmd.2025.100178_bib3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1124\/dmd.123.001508","article-title":"Cytosolic 5'-nucleotidase III and nucleoside triphosphate diphosphohydrolase 1 dephosphorylate the pharmacologically active metabolites of gemcitabine and emtricitabine","volume":"52","author":"Phulara","year":"2024","journal-title":"Drug Metab Dispos"},{"issue":"34","key":"10.1016\/j.dmd.2025.100178_bib4","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.2174\/0929867311320340005","article-title":"The role of soluble 5'-nucleotidases in the conversion of nucleotide analogs: metabolic and therapeutic aspects","volume":"20","author":"Sk\u0142adanowski","year":"2013","journal-title":"Curr Med Chem"},{"issue":"1","key":"10.1016\/j.dmd.2025.100178_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2005.01.003","article-title":"The 5'-nucleotidases as regulators of nucleotide and drug metabolism","volume":"107","author":"Hunsucker","year":"2005","journal-title":"Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.dmd.2025.100178_bib6","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.4049\/jimmunol.2001342","article-title":"Ectonucleotidases in inflammation, immunity, and cancer","volume":"206","author":"Haas","year":"2021","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100178_bib7","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1093\/nar\/gkv047","article-title":"Regulation of mammalian nucleotide metabolism and biosynthesis","volume":"43","author":"Lane","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.dmd.2025.100178_bib8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/FPC.0b013e32832c14b8","article-title":"Cytosolic 5'-nucleotidase III (NT5C3): gene sequence variation and functional genomics","volume":"19","author":"Aksoy","year":"2009","journal-title":"Pharmacogenet Genomics"},{"issue":"4","key":"10.1016\/j.dmd.2025.100178_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bcmd.2014.05.009","article-title":"Pyrimidine-5'-nucleotidase Campinas, a new mutation (p.R56G) in the NT5C3 gene associated with pyrimidine-5'-nucleotidase type I deficiency and influence of Gilbert's Syndrome on clinical expression","volume":"53","author":"Santos","year":"2014","journal-title":"Blood Cells Mol Dis"},{"issue":"1","key":"10.1016\/j.dmd.2025.100178_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s11658-022-00405-w","article-title":"A rare mutation (p.F149del) of the NT5C3A gene is associated with pyrimidine 5'-nucleotidase deficiency","volume":"27","author":"Bogus\u0142awska","year":"2022","journal-title":"Cell Mol Biol Lett"},{"issue":"13","key":"10.1016\/j.dmd.2025.100178_bib11","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.3390\/cancers14133130","article-title":"CD73 promotes chronic lymphocytic leukemia","volume":"14","author":"Allard","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.dmd.2025.100178_bib12","first-page":"187","article-title":"Fludarabine in the treatment of chronic lymphocytic leukemia: a review","volume":"5","author":"Ricci","year":"2009","journal-title":"Ther Clin Risk Manag"},{"issue":"10","key":"10.1016\/j.dmd.2025.100178_bib13","doi-asserted-by":"crossref","first-page":"e01022","DOI":"10.1128\/IAI.01022-16","article-title":"Intestinal epithelial ecto-5'-nucleotidase (CD73) regulates intestinal colonization and infection by nontyphoidal Salmonella","volume":"85","author":"Kao","year":"2017","journal-title":"Infect Immun"},{"key":"10.1016\/j.dmd.2025.100178_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119796","article-title":"Adenosine: the common target between cancer immunotherapy and glaucoma in the eye","volume":"282","author":"Hallaj","year":"2021","journal-title":"Life Sci"},{"issue":"193","key":"10.1016\/j.dmd.2025.100178_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/978-3-540-89615-9_15","article-title":"Adenosine receptors and the kidney","author":"Vallon","year":"2009","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100178_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/acr.22600","article-title":"Cytosolic 5'-nucleotidase 1A as a target of circulating autoantibodies in autoimmune diseases","volume":"68","author":"Lloyd","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.dmd.2025.100178_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ccell.2018.06.003","article-title":"Structure and mechanisms of NT5C2 mutations driving thiopurine resistance in relapsed lymphoblastic leukemia","volume":"34","author":"Dieck","year":"2018","journal-title":"Cancer Cell"},{"issue":"15","key":"10.1016\/j.dmd.2025.100178_bib18","doi-asserted-by":"crossref","first-page":"8239","DOI":"10.1073\/pnas.97.15.8239","article-title":"A deoxyribonucleotidase in mitochondria: involvement in regulation of dNTP pools and possible link to genetic disease","volume":"97","author":"Rampazzo","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.dmd.2025.100178_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/FPC.0000000000000208","article-title":"Pharmacogenetic characterization of naturally occurring germline NT5C1A variants to chemotherapeutic nucleoside analogs","volume":"26","author":"Saliba","year":"2016","journal-title":"Pharmacogenet Genomics"},{"issue":"10","key":"10.1016\/j.dmd.2025.100178_bib20","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nsb846","article-title":"Crystal structure of a human mitochondrial deoxyribonucleotidase","volume":"9","author":"Rinaldo-Matthis","year":"2002","journal-title":"Nat Struct Biol"},{"issue":"5","key":"10.1016\/j.dmd.2025.100178_bib21","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1128\/JB.06505-11","article-title":"Sinorhizobium meliloti CheA complexed with CheS exhibits enhanced binding to CheY1, resulting in accelerated CheY1 dephosphorylation","volume":"194","author":"Dogra","year":"2012","journal-title":"J Bacteriol"},{"issue":"3","key":"10.1016\/j.dmd.2025.100178_bib22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1124\/dmd.122.000855","article-title":"Nucleoside triphosphate diphosphohydrolase 1 exhibits enzymatic activity toward tenofovir diphosphate","volume":"51","author":"Seneviratne","year":"2023","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"10.1016\/j.dmd.2025.100178_bib23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.leu.2402114","article-title":"Nucleoside analogues: mechanisms of drug resistance and reversal strategies","volume":"15","author":"Galmarini","year":"2001","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.dmd.2025.100178_bib24","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2174\/0929867329666220909122820","article-title":"Prodrugs of nucleoside 5'-monophosphate analogues: overview of the recent literature concerning their synthesis and applications","volume":"30","author":"Roy","year":"2023","journal-title":"Curr Med Chem"},{"issue":"12","key":"10.1016\/j.dmd.2025.100178_bib25","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1517\/14656566.7.12.1641","article-title":"Fludarabine in chronic lymphocytic leukaemia","volume":"7","author":"Elter","year":"2006","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"10.1016\/j.dmd.2025.100178_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00003088-200241020-00002","article-title":"Cellular and clinical pharmacology of fludarabine","volume":"41","author":"Gandhi","year":"2002","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"10.1016\/j.dmd.2025.100178_bib27","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.leukres.2013.05.004","article-title":"Fludarabine: a review of the clear benefits and potential harms","volume":"37","author":"Lukenbill","year":"2013","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.dmd.2025.100178_bib28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/15257770500458027","article-title":"F-ara-AMP is a substrate of cytoplasmic 5'-nucleotidase II (cN-II): HPLC and NMR studies of enzymatic dephosphorylation","volume":"25","author":"Jordheim","year":"2006","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"7","key":"10.1016\/j.dmd.2025.100178_bib29","article-title":"Mass spectrometry imaging-based multi-omics approaches to understand drug metabolism and disposition","volume":"59","author":"Phulara","year":"2024","journal-title":"J Mass Spectrom"},{"issue":"22","key":"10.1016\/j.dmd.2025.100178_bib30","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1021\/bi301519p","article-title":"Matrix-assisted laser desorption ionization imaging mass spectrometry: in situ molecular mapping","volume":"52","author":"Angel","year":"2013","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.dmd.2025.100178_bib31","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1021\/acsptsci.4c00228","article-title":"Mass spectrometry imaging reveals region-specific lipid alterations in the mouse brain in response to efavirenz treatment","volume":"7","author":"Phulara","year":"2024","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"4","key":"10.1016\/j.dmd.2025.100178_bib32","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1021\/acsptsci.0c00015","article-title":"Spatial distribution profiles of emtricitabine, tenofovir, efavirenz, and rilpivirine in murine tissues following in vivo dosing correlate with their safety profiles in humans","volume":"3","author":"Seneviratne","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"10.1016\/j.dmd.2025.100178_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10238-024-01311-5","article-title":"Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases","volume":"24","author":"Li","year":"2024","journal-title":"Clin Exp Med"},{"issue":"1","key":"10.1016\/j.dmd.2025.100178_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/cpps.65","article-title":"In situ imaging of tryptic peptides by MALDI imaging mass spectrometry using fresh-frozen or formalin-fixed, paraffin-embedded tissue","volume":"94","author":"Angel","year":"2018","journal-title":"Curr Protoc Protein Sci"},{"issue":"10","key":"10.1016\/j.dmd.2025.100178_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.202100223","article-title":"An optimized MALDI MSI protocol for spatial detection of tryptic peptides in fresh frozen prostate tissue","volume":"22","author":"H\u00f8iem","year":"2022","journal-title":"Proteomics"},{"issue":"4","key":"10.1016\/j.dmd.2025.100178_bib36","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1021\/acs.analchem.2c04220","article-title":"MALDI-IHC-guided in-depth spatial proteomics: targeted and untargeted MSI combined","volume":"95","author":"Claes","year":"2023","journal-title":"Anal Chem"},{"issue":"40","key":"10.1016\/j.dmd.2025.100178_bib37","doi-asserted-by":"crossref","first-page":"34567","DOI":"10.1074\/jbc.M111.268292","article-title":"Suppression of 5'-nucleotidase enzymes promotes AMP-activated protein kinase (AMPK) phosphorylation and metabolism in human and mouse skeletal muscle","volume":"286","author":"Kulkarni","year":"2011","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.dmd.2025.100178_bib38","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1021\/jasms.1c00213","article-title":"Enhancement of tryptic peptide signals from tissue sections using MALDI IMS postionization (MALDI-2)","volume":"32","author":"McMillen","year":"2021","journal-title":"J Am Soc Mass Spectrom"},{"issue":"8","key":"10.1016\/j.dmd.2025.100178_bib39","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/jms.4198","article-title":"Improved spectra for MALDI MSI of peptides using ammonium phosphate monobasic in MALDI matrix","volume":"53","author":"Ucal","year":"2018","journal-title":"J Mass Spectrom"},{"issue":"3","key":"10.1016\/j.dmd.2025.100178_bib40","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1681\/ASN.2006101141","article-title":"Protective role of ecto-5'-nucleotidase (CD73) in renal ischemia","volume":"18","author":"Grenz","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.dmd.2025.100178_bib41","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2967\/jnumed.122.264453","article-title":"A realistic multiregion mouse kidney dosimetry model to support the preclinical evaluation of potential nephrotoxicity of radiopharmaceutical therapy","volume":"64","author":"Vargas","year":"2023","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.dmd.2025.100178_bib42","doi-asserted-by":"crossref","first-page":"932","DOI":"10.7150\/thno.30408","article-title":"Quantitative MALDI imaging of spatial distributions and dynamic changes of tetrandrine in multiple organs of rats","volume":"9","author":"Tang","year":"2019","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.dmd.2025.100178_bib43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0009-9120(98)00017-4","article-title":"5'-nucleotidase activity in lymphocytes from patients affected by B-cell chronic lymphocytic leukemia","volume":"31","author":"Rosi","year":"1998","journal-title":"Clin Biochem"},{"key":"10.1016\/j.dmd.2025.100178_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1362858","article-title":"Immune cell expression patterns of CD39\/CD73 ectonucleotidases in rodent models of cardiac arrest and resuscitation","volume":"15","author":"Aoki","year":"2024","journal-title":"Front Immunol"},{"issue":"1-2","key":"10.1016\/j.dmd.2025.100178_bib45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1006808232059","article-title":"Ecto-5'-nucleotidase from a human colon adenocarcinoma cell line. Correlation between enzyme activity and levels in intact cells","volume":"187","author":"Navarro","year":"1998","journal-title":"Mol Cell Biochem"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625094875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625094875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:39:04Z","timestamp":1773905944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625094875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0090955625094875"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100178","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fludarabine metabolism by cytosolic 5\u2032-nucleotidase III and its tissue-specific localization mapping using mass spectrometry imaging","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100178"}}